SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

Authors
  • L. Boekel
  • Y.R. Besten
  • F. Hooijberg
  • R. Wartena
  • M. Steenhuis
  • E. Vogelzang
  • M. Leeuw
  • S. Atiqi
  • S.W. Tas
  • W.F. Lems
  • S.M. van Ham ORCID logo
  • F. Eftimov
  • E.W. Stalman
  • L. Wieske
  • T.W. Kuijpers
  • A.E. Voskuyl
  • R.F. van Vollenhoven
  • M. Gerritsen
  • C. Krieckaert
  • T. Rispens
  • M. Boers
  • M.T. Nurmohamed
  • G. Wolbink
Publication date 11-2022
Journal The Lancet. Rheumatology
Volume | Issue number 4 | 11
Pages (from-to) e747-e750
Number of pages 4
Organisations
  • Faculty of Science (FNWI) - Swammerdam Institute for Life Sciences (SILS)
Document type Article
Note Comment to: J.W. Liew, S.E. Sattui (2022) Omicron breakthrough infections in patients with immune-mediated inflammatory diseases, in: The Lancet Rheumatology, v. 4, iss. 11, p. e751-e752.
Language English
Published at https://doi.org/10.1016/S2665-9913(22)00221-1
Permalink to this page
Back